Bristol Myers Squibb Polska Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 – 296,600,000 PLN
2021 – 353,400,000 PLN
2022 – 405,100,000 PLN
2023 – 536,800,000 PLN
2024 – 691,600,000 PLN
Bristol Myers Squibb Poland is a bio-pharmaceutical company operating since 1994 with commercial and clinical research activities in Central and Eastern Europe, focusing on oncology, hematology, and cardiology treatments. It maintains a regional clinical research office in Warsaw and collaborates on patient education and disease prevention.